Țară: Canada
Limbă: engleză
Sursă: Health Canada
LORAZEPAM
SIVEM PHARMACEUTICALS ULC
N05BA06
LORAZEPAM
0.5MG
TABLET
LORAZEPAM 0.5MG
ORAL
100/500
Targeted (CDSA IV)
BENZODIAZEPINES
Active ingredient group (AIG) number: 0110731003; AHFS:
CANCELLED PRE MARKET
2018-07-03
PRODUCT MONOGRAPH LORAZEPAM LORAZEPAM TABLETS USP 0.5 MG, 1 MG AND 2 MG ANXIOLYTIC-SEDATIVE SIVEM PHARMACEUTICALS ULC 4705 DOBRIN STREET SAINT-LAURENT, QUÉBEC H4R 2P7 DATE OF PREPARATION: AUGUST 20, 2014 CONTROL NO. : 176952 Lorazepam Product Monograph Page 2 of 24 TABLE OF CONTENTS PRESCRIBING INFORMATION ............................................................................................. 1 ACTIONS AND CLINICAL PHARMACOLOGY ....................................................................... 3 INDICATIONS AND CLINICAL USE ....................................................................................... 6 CONTRAINDICATIONS .......................................................................................................... 6 WARNINGS ........................................................................................................................... 6 PRECAUTIONS ...................................................................................................................... 7 DRUG INTERACTIONS .......................................................................................................... 9 ADVERSE REACTIONS ....................................................................................................... 10 SYMPTOMS AND TREATMENT OF OVERDOSE ............................................................... 11 DOSAGE AND ADMINISTRATION ....................................................................................... 11 AVAILABILITY OF DOSAGE FORMS .................................................................................. 12 PHARMACEUTICAL INFORMATION ................................................................................... 13 PHARMACOLOGY................................................................................................................ 14 TOXICOLOGY....................................................................................................................... 16 REFERENCES ................................................. Citiți documentul complet